ArticleOncotarget2018

Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.

Güliz Acker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.